Medical Xpress news
Medical Xpress / Lab-grown aging eye model reveals early AMD markers in weeks
The rods and cones in your eyes are responsible for helping you see, but what is responsible for helping them? Retinal pigment epithelium cells are their caretakers, but environmental, genetic and aging factors can strain ...
Medical Xpress / Study proposes reconsidering how histone deacetylase inhibitors work in cancer treatment
Researchers at Baylor College of Medicine and collaborating institutions are challenging the traditional understanding of how cancer drugs called histone deacetylase (HDAC) inhibitors function. For decades, scientists believed ...
Medical Xpress / Simple leukemia treatment change in India cuts early child deaths
A landmark Indian clinical trial has found that giving steroids in short bursts instead of continuously can halve early treatment-related deaths in children with leukemia without reducing their chances of being cured. The ...
Medical Xpress / Autism may have two distinct subtypes based on brain connectivity patterns
Autism spectrum disorder (ASD), commonly referred to as autism, is a neurodevelopmental condition characterized by differences in social interactions, communication, behavior and the processing of sensory stimuli. Notably, ...
Medical Xpress / First AI-designed 'universal vaccine' tested in humans: UK researchers
A vaccine targeting a broad range of viruses that was designed using artificial intelligence had a "modest" effect on immune systems in a small, early trial, according to a new study.
Medical Xpress / Some tumors eliminate healthy neighboring cells to grow, study reveals
Chromosomal instability is a common feature in many solid tumors and is associated with greater aggressiveness. For years, its main contribution to cancer was thought to be driving the evolution of tumor genomes, causing ...
Medical Xpress / Antibody fragment prevents hemorrhages associated with new Alzheimer's treatments
In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (LeqembiTM, from Biogen) and donanemab (Kisunla, from Eli Lilly and Co.), both based on immunotherapy (the use of molecules ...
Medical Xpress / Researchers discover way to inhibit brain cancer's infiltration mechanism in glioblastoma
A team of experimental oncology researchers at the University of Alberta is shedding light on how the deadly brain cancer glioblastoma spreads. In newly published research, they identify a potential treatment target to slow ...
Medical Xpress / Common arthritis drugs reduce systemic Sjögren's disease activity in 24 weeks
A combination of two widely available anti-rheumatic drugs offers the first effective and affordable treatment for patients with Sjögren's disease with systemic disease activity, according to new results from a clinical trial ...
Medical Xpress / First leishmaniasis vaccine enters phase one trial as disease spreads to US
A phase 1 clinical trial testing the safety of a leishmaniasis vaccine is set to begin in the coming months—the first vaccine created to protect against the disfiguring skin disease common in tropical regions of the world ...
Medical Xpress / Cohort makes data from more than 5,800 patients hospitalized with COVID-19 available to the scientific community
The Biostatistics Unit at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with researchers from several Catalan health care and research institutions, has published the DIVINE study database in Scientific ...
Medical Xpress / Vitamin A poisonings rose almost 40% as measles misinformation spread in 2025
There can be too much of a good thing, and that has been the case with Vitamin A in the U.S.. A recent study in JAMA Network Open has found that between January and March 2025, America's Poison Centers reported a 38.7% increase ...
